Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement

Dirk De Ruysscher, Gilles Defraene, Bram L. T. Ramaekers, Philippe Lambin, Erik Briers, Hilary Stobart, Tim Ward, Soren M. Bentzen, Tjeerd Van Staa, David Azria, Barry Rosenstein, Sarah Kerns, Catharine West

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)440-446
JournalRadiotherapy and Oncology
Issue number3
Publication statusPublished - Dec 2016


  • Trial design
  • Patient selection
  • Radiogenomics
  • Biomarkers

Cite this